Jacobi Capital Management’s Bio-Techne TECH Stock Holding History

Jacobi Capital Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-184	Closed	-$22K	–	1226
2021 Q3	$22K	Buy	+184	New	+$22.4K	﹤0.01%	850

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Jacobi Capital Management's TECH Position: Q4 2021 in Review

Jacobi Capital Management sold out of Bio-Techne (TECH) in Q4 2021, closing a stake of 184 shares — an estimated $22K sold.

Jacobi Capital Management first reported a position in TECH in Q3 2021 and held it in 1 quarter. The position peaked at $22K in Q3 2021. 575 funds tracked by Wall St. Rank hold TECH as of Q4 2021.

Jacobi Capital Management reported no remaining Bio-Techne position as of Q4 2021 after selling out during the quarter.
Jacobi Capital Management sold 184 Bio-Techne shares in Q4 2021, an estimated $22K.
Jacobi Capital Management first reported a position in Bio-Techne in Q3 2021 and held it in 1 quarter.
Jacobi Capital Management's Bio-Techne position peaked at $22K in Q3 2021.
575 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2021.

Based on Jacobi Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.